A detailed history of Brave Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Brave Asset Management Inc holds 10,090 shares of JNJ stock, worth $1.57 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
10,090
Previous 10,090 -0.0%
Holding current value
$1.57 Million
Previous $1.47 Million 10.92%
% of portfolio
0.4%
Previous 0.38%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$144.38 - $157.78 $58,040 - $63,427
402 Added 4.15%
10,090 $1.47 Million
Q1 2024

Apr 29, 2024

BUY
$155.22 - $162.74 $299,264 - $313,762
1,928 Added 24.85%
9,688 $1.53 Million
Q4 2023

Jan 18, 2024

SELL
$145.6 - $158.88 $10,192 - $11,121
-70 Reduced 0.89%
7,760 $1.22 Million
Q3 2023

Oct 13, 2023

SELL
$155.75 - $174.48 $23,362 - $26,172
-150 Reduced 1.88%
7,830 $1.22 Million
Q1 2023

Apr 12, 2023

BUY
$151.05 - $180.26 $22,657 - $27,039
150 Added 1.92%
7,980 $1.24 Million
Q2 2022

Jul 15, 2022

BUY
$168.19 - $186.01 $20,182 - $22,321
120 Added 1.56%
7,830 $1.39 Million
Q1 2022

Apr 22, 2022

BUY
$158.14 - $179.59 $236,261 - $268,307
1,494 Added 24.03%
7,710 $1.37 Million
Q4 2021

Jan 21, 2022

SELL
$155.93 - $173.01 $19,023 - $21,107
-122 Reduced 1.92%
6,216 $1.06 Million
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $3,391 - $3,768
21 Added 0.33%
6,338 $1.02 Million
Q2 2021

Jul 27, 2021

BUY
$159.48 - $171.07 $1,913 - $2,052
12 Added 0.19%
6,317 $1.04 Million
Q4 2020

Jan 27, 2021

SELL
$137.11 - $157.38 $8,226 - $9,442
-60 Reduced 0.94%
6,305 $992,000
Q2 2020

Jul 23, 2020

SELL
$128.81 - $155.51 $1,674 - $2,021
-13 Reduced 0.2%
6,365 $895,000
Q4 2019

Jan 17, 2020

SELL
$127.5 - $146.44 $522,495 - $600,111
-4,098 Reduced 39.12%
6,378 $930,000
Q3 2019

Oct 24, 2019

SELL
$126.95 - $142.14 $25,390 - $28,427
-200 Reduced 1.87%
10,476 $1.36 Million
Q2 2019

Aug 05, 2019

SELL
$131.15 - $144.24 $450,237 - $495,175
-3,433 Reduced 24.33%
10,676 $1.49 Million
Q1 2019

May 03, 2019

SELL
$125.72 - $139.79 $10,686 - $11,882
-85 Reduced 0.6%
14,109 $1.97 Million
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $185,365 - $223,090
-1,509 Reduced 9.61%
14,194 $1.83 Million
Q1 2018

Apr 26, 2018

SELL
$125.1 - $148.14 $75,060 - $88,883
-600 Reduced 3.68%
15,703 $2.01 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $44,614 - $48,830
-340 Reduced 2.04%
16,303 $2.28 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $2.15 Million - $2.25 Million
16,643
16,643 $2.16 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.